Skip to content

Top 5 HIV cure and vaccine stories from CROI 2022

Professor Yvonne Bryson (top centre) presenting the HIV remission case at CROI 2022.

Top 5 stories on HIV prevention from CROI 2022

Professor Raphael Landovitz (bottom left) presenting the latest data on injected PrEP at CROI 2022.

Top 5 stories on HIV, ageing and co-morbidities from CROI 2022

Professor Joel Palefsky, presenting the results of the anal screening trial, at CROI 2022. CROI 2022.

Top 5 stories on HIV treatment and care in Africa from CROI 2022

Maya Jackson-Gibson presenting the study on COVID-19 and adverse birth outcomes at CROI 2022.

Generic PrEP for young, at-risk MSM in the US could be cost-saving and health-enhancing

Image by Doctor 4U. Creative Commons licence.

Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?

Dr Boris Juelg (bottom left) and Dr Marina Caskey (bottom right) at CROI 2022.

Why did an HIV vaccine fail in the Imbokodo trial?

Dr Glenda Gray (bottom right) at CROI 2022.

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV

Professor Samir Gupta (top right) at CROI 2022.

Injected PrEP: breakthrough cases could have been detected sooner

Professor Susan Eshleman (top right) at CROI 2022.